M&T Bank’s Clovis Oncology, Inc. CLVS Stock Holding History

M&T Bank’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,744	Closed	-$207K	–	1776
2016 Q3	$207K	Buy	+5,744	New	+$123K	﹤0.01%	1482

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

M&T Bank's CLVS Position: Q4 2016 in Review

M&T Bank sold out of Clovis Oncology, Inc. (CLVS) in Q4 2016, closing a stake of 5,744 shares — an estimated $207K sold.

M&T Bank first reported a position in CLVS in Q3 2016 and held it in 1 quarter. The position peaked at $207K in Q3 2016. 167 funds tracked by Wall St. Rank hold CLVS as of Q4 2016.

M&T Bank reported no remaining Clovis Oncology, Inc. position as of Q4 2016 after selling out during the quarter.
M&T Bank sold 5,744 Clovis Oncology, Inc. shares in Q4 2016, an estimated $207K.
M&T Bank first reported a position in Clovis Oncology, Inc. in Q3 2016 and held it in 1 quarter.
M&T Bank's Clovis Oncology, Inc. position peaked at $207K in Q3 2016.
167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2016.

Based on M&T Bank's 13F filing for Q4 2016, filed 14 Feb 2017.